Have hundreds of animal models of autoimmune diseases based on clinical features and target mechanisms of action, and have evaluated various forms of innovative drugs on these models; And has more than 10 kinds of NHP autoimmune disease models; More autoimmune disease models are being developed;
Rich experience in the research and development of new drugs for autoimmune diseases, good at exploring the differentiation advantages of innovative drugs for autoimmune diseases, so as to accelerate the process of new drug research and development;
Rich experience in IND declaration at home and abroad, familiar with communication strategies and skills with FDA and NMPA in preclinical research;
Rich experience in the exploration and development of molecular and cellular biomarkers, and can develop specific biomarkers for different targets of new drugs and different autoimmune indications;
Experienced in the development and detection of in vitro immune function methodology, it can detect the functional changes of different T cell subtypes, B cells, NK cells, macrophages and other immune cells.
HKeybio is a Contract Research Organization (CRO) specializing in preclinical research within the field of autoimmune diseases.